StatFinn and EPID present strong growth in 2016

(Espoo, Finland, 11.4.2017) StatFinn and EPID Research achieved a strong and profitable growth in 2016. Following the 2-digit growth from the previous financial year, the results show that the merged company continues the global expansion with solid basis, resources and talent. Read more details in the official press release.


StatFinn and EPID Research join forces in clinical data analytics and Real-World Evidence

(Espoo, Finland, 16.1.2017) StatFinn and EPID Research have decided to merge their operations in order to offer a full range of services to their clients in clinical data analytics and Real-World Evidence from Phase I to Phase IV and beyond. The combined company employs over 70 experts with presence in five countries: Estonia, Finland, Poland, Sweden and Switzerland. The new combination will carry on using both brands StatFinn and EPID Research.